Riboflavin-UVA-induced corneal collagen cross-linking in pediatric patients

Purpose:Evaluation of stability and functional response after riboflavin-UVA–induced cross-linking in a population of patients younger than 18 years with progressive keratoconus after 36 months of follow-up.Methods:Prospective nonrandomized phase II open trial conducted at the Department of Ophthalm